Cargando…
Efficacy and safety of cyclooxygenase 2 inhibitors for desmoid tumor management: a systematic review
The efficacy and safety of cyclooxygenase 2 (COX2) inhibitors for the treatment of desmoid-type fibromatosis (DF) are unclear. Therefore, we systematically reviewed related literature to assess the efficacy and safety of COX2 inhibitors for DF treatment. We searched pertinent literature between Janu...
Autores principales: | Emori, Makoto, Matsumoto, Yoshihiro, Murahashi, Yasutaka, Yoshida, Masahiro, Nishida, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nagoya University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648529/ https://www.ncbi.nlm.nih.gov/pubmed/34916712 http://dx.doi.org/10.18999/nagjms.83.4.673 |
Ejemplares similares
-
Desmoid tumor-associated pain is dependent on mast cell expression of cyclooxygenase-2
por: Emori, Makoto, et al.
Publicado: (2014) -
Efficacy of auranofin as an inhibitor of desmoid progression
por: Ito, Kan, et al.
Publicado: (2022) -
Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
por: Curtis, Elizabeth, et al.
Publicado: (2019) -
Transition of Treatment for Patients with Extra-Abdominal Desmoid Tumors: Nagoya University Modality
por: Nishida, Yoshihiro, et al.
Publicado: (2012) -
CTNNB1 S45F Mutation Predicts Poor Efficacy of Meloxicam Treatment for Desmoid Tumors: A Pilot Study
por: Hamada, Shunsuke, et al.
Publicado: (2014)